Global Adult Hemoglobinopathy Testing Market to Reach $447.8 Million by 2027 - ResearchAndMarkets.com
09 Dec 2022
DUBLIN--(BUSINESS WIRE)--The "Adult Hemoglobinopathy Testing: Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
'Adult Hemoglobinopathy Testing: Global Strategic Business Report'
Global Adult Hemoglobinopathy Testing Market to Reach $447.8 Million by 2027
In the changed post COVID-19 business landscape, the global market for Adult Hemoglobinopathy Testing estimated at US$343.8 Million in the year 2020, is projected to reach a revised size of US$447.8 Million by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. HPLC Test, one of the segments analyzed in the report, is projected to record a 3.6% CAGR and reach US$276.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mass Spectrometry segment is readjusted to a revised 4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $93 Million, While China is Forecast to Grow at 6.2% CAGR
The Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$93 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$89.5 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$58.8 Million by the year 2027.
Hb Electrophoresis Segment to Record 4.8% CAGR
In the global Hb Electrophoresis segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39 Million in the year 2020 will reach a projected size of US$53.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.2% CAGR through the analysis period.
Select Competitors (Total 44 Featured) -
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Adult Hemoglobinopathy Testing - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/5arxhm
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.